EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Resolvin D4 mitigates lipopolysaccharide-induced lung injury in mice

Rika Inomata, Hironobu Tsubouchi, Toshifumi Takao, Mone Kurokawa, Shigehisa Yanagi, Katsuya Sakai, Taiga Miyazaki

Prostaglandins, Leukotrienes and Essential Fatty Acids · 2024

DOI: 10.1016/j.plefa.2024.102652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prostaglandins, Leukotrienes and Essential Fatty Acids, 2024. Verfasst von Rika Inomata und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyaza…. Hauptthemen laut MEDLINE: Lipopolysaccharides, Sirtuin 3. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, University of Miyazaki Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute respiratory distress syndrome (ARDS) is a life-threatening condition involving severe lung inflammation. The excessive oxidative stress and persistent inflammation that occur in ARDS lead to decreased epithelial integrity and hypoxemia due to pulmonary edema via increased vascular permeability. Resolvin D4 (RvD4) is one of the lipid mediators that is biosynthesized from omega-3 polyunsaturated fatty acids. It plays a role in the resolution of inflammation and reduces oxidative stress and cell death. We investigated the therapeutic potential of the administration of RvD4 in a murine model of lipopolysaccharide (LPS)-induced ARDS. Concurrent with the intratracheal administration of LPS, RvD4 or saline was administered to mice via the caudal vein every 12 h. This treatment with RvD4 alleviated the LPS-induced infiltration of inflammatory cells in lungs, inhibited increased pulmonary vascular permeability, decreased the levels of IL-1β, IL-6, and TNF-α in bronchoalveolar lavage fluid (BALF), and suppressed the reduction of the expression levels of the tight junction protein, Zonula occludens-1 (Zo-1) and the NAD+-dependent deacetylase, Sirtuin-3 (Sirt3). In vitro experiments revealed that in LPS-stimulated BEAS-2B cells, treatment with RvD4 suppressed the increases in the expressions of pro-inflammatory cytokines and maintained the epithelial cell barrier function and cell viability. The silencing of SIRT3 abolished both the anti-inflammatory effect and the retention of cell integrity in BEAS-2B cells. Together these results indicate that treatment with RvD4 can (i) protect against LPS-induced lung injury by inhibiting inflammation, and (ii) maintain epithelial barrier function via a reduction in the downregulation of SIRT3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesSirtuin 3AnimalsMiceMaleZonula Occludens-1 ProteinRespiratory Distress SyndromeBronchoalveolar Lavage FluidLungDisease Models, AnimalCell LineCapillary PermeabilityHumansCytokinesMice, Inbred C57BLDocosahexaenoic Acids

Stichwörter der Autor:innen

ARDSInflammationOmega-3 epoxyeicosanoidOxidative stressSirtuin-3

Substanzen

LipopolysaccharidesSirtuin 3Sirt3 protein, mouseZonula Occludens-1 ProteinTjp1 protein, mouseCytokinesDocosahexaenoic Acids

Autor:innen und Institutionen

  • Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Kihara 5200, Kiyotake, Miyazaki, 889-1692, Japan.
  • Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Kihara 5200, Kiyotake, Miyazaki, 889-1692, Japan. Electronic addre…
  • Institute for Protein Research, Osaka University, Osaka, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • University of Miyazaki Hospital

Zitieren

APA

Inomata, R., Tsubouchi, H., Takao, T., Kurokawa, M., Yanagi, S., Sakai, K., & Miyazaki, T. (2024). Resolvin D4 mitigates lipopolysaccharide-induced lung injury in mice. Prostaglandins, Leukotrienes and Essential Fatty Acids. https://doi.org/10.1016/j.plefa.2024.102652

Vancouver

Inomata R, Tsubouchi H, Takao T, Kurokawa M, Yanagi S, Sakai K, et al. Resolvin D4 mitigates lipopolysaccharide-induced lung injury in mice. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2024. doi:10.1016/j.plefa.2024.102652

BibTeX
@article{Inomata2024,
  author = {Inomata, Rika and Tsubouchi, Hironobu and Takao, Toshifumi and Kurokawa, Mone and Yanagi, Shigehisa and Sakai, Katsuya and Miyazaki, Taiga},
  title = {Resolvin D4 mitigates lipopolysaccharide-induced lung injury in mice},
  journal = {Prostaglandins, Leukotrienes and Essential Fatty Acids},
  year = {2024},
  doi = {10.1016/j.plefa.2024.102652}
}
Kostenlos starten →